 Alpna Tyagi
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuin 3 | 4 | 2023 | 52 | 2.380 |
Why?
| | Metabolic Syndrome | 4 | 2023 | 323 | 2.370 |
Why?
| | Grape Seed Extract | 6 | 2019 | 41 | 1.780 |
Why?
| | Alzheimer Disease | 4 | 2023 | 436 | 1.380 |
Why?
| | Antineoplastic Agents, Phytogenic | 7 | 2019 | 181 | 1.340 |
Why?
| | Silymarin | 13 | 2011 | 194 | 1.120 |
Why?
| | Anthocyanins | 2 | 2019 | 29 | 1.070 |
Why?
| | Apoptosis | 15 | 2019 | 2371 | 0.970 |
Why?
| | Plaque, Amyloid | 2 | 2022 | 15 | 0.920 |
Why?
| | Amyloid | 3 | 2023 | 80 | 0.920 |
Why?
| | Insulysin | 1 | 2022 | 1 | 0.850 |
Why?
| | Anticarcinogenic Agents | 4 | 2013 | 67 | 0.770 |
Why?
| | Stilbenes | 4 | 2013 | 36 | 0.760 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 91 | 0.760 |
Why?
| | Prostatic Neoplasms | 5 | 2019 | 925 | 0.730 |
Why?
| | STAT3 Transcription Factor | 6 | 2013 | 174 | 0.730 |
Why?
| | Proanthocyanidins | 1 | 2019 | 8 | 0.650 |
Why?
| | Biflavonoids | 1 | 2019 | 8 | 0.650 |
Why?
| | Catechin | 1 | 2019 | 23 | 0.640 |
Why?
| | Mitochondria | 3 | 2023 | 751 | 0.620 |
Why?
| | Urinary Bladder Neoplasms | 4 | 2013 | 196 | 0.620 |
Why?
| | Inflammasomes | 1 | 2018 | 115 | 0.580 |
Why?
| | Nitric Oxide Synthase Type II | 4 | 2011 | 157 | 0.570 |
Why?
| | NF-kappa B | 5 | 2013 | 637 | 0.550 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 334 | 0.500 |
Why?
| | Carcinogens | 3 | 2013 | 105 | 0.410 |
Why?
| | Cell Line, Tumor | 11 | 2013 | 2725 | 0.410 |
Why?
| | Receptors, Androgen | 1 | 2013 | 131 | 0.410 |
Why?
| | Lung Neoplasms | 5 | 2011 | 2223 | 0.400 |
Why?
| | Brain | 3 | 2023 | 2372 | 0.390 |
Why?
| | Cyclooxygenase 2 | 2 | 2011 | 164 | 0.380 |
Why?
| | Down-Regulation | 6 | 2022 | 596 | 0.380 |
Why?
| | Smad4 Protein | 1 | 2011 | 34 | 0.380 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 536 | 0.380 |
Why?
| | Mice | 14 | 2023 | 14936 | 0.350 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 107 | 0.350 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2013 | 584 | 0.340 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 4 | 2011 | 146 | 0.320 |
Why?
| | Cell Proliferation | 9 | 2019 | 2199 | 0.320 |
Why?
| | DNA Damage | 1 | 2011 | 357 | 0.320 |
Why?
| | Neovascularization, Pathologic | 3 | 2010 | 283 | 0.320 |
Why?
| | Interferon-gamma | 1 | 2011 | 723 | 0.300 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 2007 | 6 | 0.300 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2013 | 447 | 0.300 |
Why?
| | Autocrine Communication | 1 | 2008 | 42 | 0.300 |
Why?
| | Transforming Growth Factor alpha | 1 | 2008 | 53 | 0.300 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2008 | 38 | 0.300 |
Why?
| | Cell Survival | 3 | 2019 | 1022 | 0.290 |
Why?
| | Interleukin-1beta | 2 | 2020 | 370 | 0.280 |
Why?
| | Angiogenesis Inhibitors | 1 | 2009 | 215 | 0.280 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 436 | 0.280 |
Why?
| | Caspase 2 | 1 | 2006 | 14 | 0.270 |
Why?
| | cdc25 Phosphatases | 2 | 2006 | 12 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1134 | 0.270 |
Why?
| | CDC2 Protein Kinase | 2 | 2006 | 25 | 0.270 |
Why?
| | Animals | 15 | 2023 | 31839 | 0.250 |
Why?
| | S Phase | 1 | 2005 | 70 | 0.250 |
Why?
| | Cell Cycle | 4 | 2011 | 544 | 0.240 |
Why?
| | ErbB Receptors | 1 | 2008 | 561 | 0.240 |
Why?
| | Tyrosine | 1 | 2005 | 216 | 0.240 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 164 | 0.230 |
Why?
| | Signal Transduction | 6 | 2011 | 4525 | 0.230 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 855 | 0.220 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2011 | 1148 | 0.220 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2022 | 21 | 0.210 |
Why?
| | Phosphorylation | 5 | 2013 | 1572 | 0.200 |
Why?
| | Adenocarcinoma | 1 | 2009 | 801 | 0.200 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2022 | 73 | 0.200 |
Why?
| | Cell Movement | 2 | 2019 | 867 | 0.190 |
Why?
| | STAT1 Transcription Factor | 2 | 2011 | 65 | 0.190 |
Why?
| | Male | 16 | 2020 | 55663 | 0.190 |
Why?
| | Ovarian Neoplasms | 1 | 2005 | 388 | 0.180 |
Why?
| | MAP Kinase Signaling System | 2 | 2013 | 276 | 0.180 |
Why?
| | Carcinoma | 3 | 2011 | 199 | 0.180 |
Why?
| | Caspase 9 | 2 | 2013 | 48 | 0.180 |
Why?
| | Amyloidosis | 1 | 2020 | 36 | 0.170 |
Why?
| | Antineoplastic Agents | 5 | 2013 | 1897 | 0.170 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3549 | 0.170 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 222 | 0.170 |
Why?
| | Cytochromes c | 2 | 2013 | 63 | 0.170 |
Why?
| | Immunoblotting | 2 | 2011 | 283 | 0.170 |
Why?
| | Jagged-1 Protein | 1 | 2019 | 23 | 0.160 |
Why?
| | Caspase 3 | 2 | 2013 | 238 | 0.160 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 43 | 0.160 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1635 | 0.160 |
Why?
| | Mice, Nude | 5 | 2011 | 635 | 0.160 |
Why?
| | Receptor, Notch1 | 1 | 2019 | 61 | 0.160 |
Why?
| | Spheroids, Cellular | 1 | 2019 | 58 | 0.160 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 66 | 0.160 |
Why?
| | Diet, Western | 1 | 2018 | 66 | 0.150 |
Why?
| | Microglia | 1 | 2020 | 202 | 0.150 |
Why?
| | Caspase 1 | 1 | 2018 | 140 | 0.150 |
Why?
| | Xenograft Model Antitumor Assays | 5 | 2011 | 706 | 0.150 |
Why?
| | Prostate | 1 | 2019 | 157 | 0.150 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 144 | 0.150 |
Why?
| | Cell Cycle Proteins | 4 | 2010 | 552 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2013 | 1084 | 0.140 |
Why?
| | Fatty Acids | 1 | 2018 | 382 | 0.130 |
Why?
| | In Situ Nick-End Labeling | 3 | 2013 | 119 | 0.130 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 752 | 0.130 |
Why?
| | Humans | 18 | 2023 | 114937 | 0.120 |
Why?
| | Mice, Knockout | 2 | 2018 | 2587 | 0.120 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 8 | 0.110 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 20 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 975 | 0.110 |
Why?
| | Colorectal Neoplasms | 2 | 2010 | 621 | 0.110 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2013 | 13 | 0.110 |
Why?
| | Vitis | 1 | 2013 | 38 | 0.100 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2013 | 88 | 0.100 |
Why?
| | Seeds | 1 | 2013 | 76 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2013 | 175 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2020 | 1072 | 0.100 |
Why?
| | Comet Assay | 1 | 2011 | 18 | 0.100 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2011 | 57 | 0.100 |
Why?
| | Microtubule-Associated Proteins | 2 | 2013 | 174 | 0.090 |
Why?
| | Cyclin D1 | 2 | 2008 | 61 | 0.090 |
Why?
| | BRCA1 Protein | 1 | 2011 | 56 | 0.090 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2011 | 68 | 0.090 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 119 | 0.090 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 82 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 797 | 0.080 |
Why?
| | Antioxidants | 2 | 2010 | 530 | 0.080 |
Why?
| | Checkpoint Kinase 2 | 2 | 2006 | 21 | 0.080 |
Why?
| | Transfection | 1 | 2011 | 870 | 0.080 |
Why?
| | Azoxymethane | 1 | 2008 | 16 | 0.080 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2006 | 63 | 0.080 |
Why?
| | beta Catenin | 1 | 2010 | 220 | 0.080 |
Why?
| | Microvessels | 1 | 2009 | 68 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 15 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2008 | 18 | 0.080 |
Why?
| | Up-Regulation | 1 | 2011 | 812 | 0.070 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 109 | 0.070 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2008 | 54 | 0.070 |
Why?
| | Blotting, Western | 4 | 2011 | 1151 | 0.070 |
Why?
| | Precancerous Conditions | 1 | 2008 | 158 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2008 | 1856 | 0.070 |
Why?
| | Gallic Acid | 1 | 2006 | 13 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 2 | 2006 | 282 | 0.070 |
Why?
| | Toluene | 1 | 2006 | 11 | 0.070 |
Why?
| | Histones | 1 | 2011 | 536 | 0.070 |
Why?
| | Androgens | 1 | 2008 | 167 | 0.070 |
Why?
| | Benzothiazoles | 1 | 2006 | 33 | 0.070 |
Why?
| | Epithelial Cells | 1 | 2011 | 958 | 0.060 |
Why?
| | Ataxia Telangiectasia | 1 | 2005 | 17 | 0.060 |
Why?
| | Ribonucleotide Reductases | 1 | 2005 | 21 | 0.060 |
Why?
| | Checkpoint Kinase 1 | 1 | 2005 | 28 | 0.060 |
Why?
| | Neurofibrillary Tangles | 1 | 2023 | 13 | 0.060 |
Why?
| | Intestinal Mucosa | 1 | 2008 | 530 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2011 | 3897 | 0.060 |
Why?
| | Protein Kinases | 1 | 2005 | 307 | 0.050 |
Why?
| | Multigene Family | 1 | 2023 | 193 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2011 | 790 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2006 | 1317 | 0.050 |
Why?
| | Macrophages | 1 | 2009 | 1266 | 0.050 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 189 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1843 | 0.050 |
Why?
| | Mutation | 1 | 2011 | 3354 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2008 | 2559 | 0.040 |
Why?
| | Female | 3 | 2020 | 59581 | 0.040 |
Why?
| | Cell Death | 2 | 2013 | 325 | 0.040 |
Why?
| | Janus Kinase 1 | 2 | 2011 | 23 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1630 | 0.040 |
Why?
| | Time Factors | 1 | 2008 | 6125 | 0.040 |
Why?
| | Tongue | 1 | 2013 | 67 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2013 | 85 | 0.030 |
Why?
| | Cytoplasm | 1 | 2013 | 255 | 0.030 |
Why?
| | Superoxides | 1 | 2013 | 214 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2013 | 180 | 0.030 |
Why?
| | HT29 Cells | 1 | 2011 | 36 | 0.020 |
Why?
| | Autophagy | 1 | 2013 | 234 | 0.020 |
Why?
| | Nestin | 1 | 2010 | 16 | 0.020 |
Why?
| | Urethane | 1 | 2010 | 41 | 0.020 |
Why?
| | Intermediate Filament Proteins | 1 | 2010 | 65 | 0.020 |
Why?
| | X-Ray Microtomography | 1 | 2010 | 74 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 86 | 0.020 |
Why?
| | Genes, APC | 1 | 2010 | 13 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2010 | 71 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2010 | 38 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 262 | 0.020 |
Why?
| | DNA Primers | 1 | 2011 | 514 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 396 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 356 | 0.020 |
Why?
| | Wnt Proteins | 1 | 2010 | 135 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 305 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 49 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2010 | 350 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2008 | 241 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 165 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 995 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2008 | 42 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 927 | 0.020 |
Why?
| | Janus Kinase 2 | 1 | 2007 | 31 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2118 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 529 | 0.020 |
Why?
| | Cyclins | 1 | 2006 | 78 | 0.020 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2006 | 111 | 0.020 |
Why?
| | Caspases | 1 | 2006 | 245 | 0.020 |
Why?
| | Administration, Oral | 1 | 2008 | 731 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2008 | 368 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 4719 | 0.010 |
Why?
| | Rats | 1 | 2008 | 4963 | 0.010 |
Why?
| | Lung | 1 | 2010 | 3593 | 0.010 |
Why?
|
|
Tyagi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|